Roche (ROG.SW) Financial Analysis & Valuation | Quarter Chart
Roche (ROG.SW)
ROG.SWPrice: $408.14
Fair Value: 🔒
🔒score
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunolog... more
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, ... more
Description
Shares
| Market Cap | $324.88B | Exchange | SIX |
| Sector | Healthcare | Industry | Drug Manufacturers - General |
| Country | CH | CEO | Thomas Schinecker |
| IPO Date | 1995-08-03 | CAGR | 0.03% |
| Employees | 103,249 | Website | www.roche.com |
| Div. Yield | 3% | Payout Ratio | 0.49% |
| Buy Back Yield | 0.7% | Total Yield | 3.7% |
ROG.SW chart loading...
Fundamentals
Technicals
| Enterprise Value | $246.32B | P/E Ratio | 19.97 |
| Forward P/E | 14.82 | PEG Ratio | 0.12 |
| P/S Ratio | 5.52 | P/B Ratio | 7.65 |
| P/CF Ratio | 17.47 | P/FCF Ratio | 21.74 |
| EPS | $20.44 | EPS Growth 1Y | -34.24% |
| EPS Growth 3Y | -29.85% | EPS Growth 5Y | -7.4% |
| Revenue Growth 1Y | -9.93% | Gross Margin | 0.73% |
| Operating Margin | 0.26% | Profit Margin | 0.2% |
| ROE | 0.29% | ROA | 0.09% |
| ROCE | 0.17% | Current Ratio | 1.38 |
| Quick Ratio | 1.12 | Cash Ratio | 0.2 |
| Debt/Equity | 0.94 | Interest Coverage | 9.1 |
| Altman Z Score | 4.37 | Piotroski Score | 7 |